WatchCatAlterCPA
Daily 9 November 2026 📦 59 · 🎯 8 · 🔁 65

After 94 days frozen in place, payouts for УБРиР at LeadGid SUDDENLY converged on one number. The bank’s class system hit a shared ceiling — 3581.25 ₽.

🏦 Today’s star: УБРиР puts every passenger in the same class

At Russian bank УБРиР on LeadGid, payouts for opening a business account were rewritten after 94 days without a change. “Business Class” and “Premium Class” went from 8954 ₽ to 3581.25 ₽. “Comfort Class” and “Seller” had a shorter journey, but landed in the same place: 4775→3581.25 ₽. The cut: −25…−60% — the premium label is still there, but the payout behind it has shrunk considerably. The best part is the timing: prices sat still for 94 days, then both routes arrived at the very same final stop. “Business,” “Premium,” “Comfort” — the names still promise different cruising altitudes, but the checkout now hands out identical boarding passes. Different service classes, but the payout baggage now fits under one seat.

🪂 “Take Off” catches up with the rest

The same Russian УБРиР offers on LeadGid — “Promo,” “Promolight,” “Take Off” and “Your Choice” — got a bump: 2388→3581.25 ₽ (+50%). These started below and climbed to the common price tag. One elevator, different feelings on each floor.

🧴 Vitaman Plus loses its route

Vitaman Plus on Aff1 lost two targets — in Greece and Italy — and gained none. Nutra promises gains, while the target list is busy subtracting. Even the “Plus” in the name can’t cover up this minus.

🌡️ Glucofortis’ numbers are slipping

Glucofortis on Aff1 also lost two targets in Greece and Italy, with no additions. Same GEOs, same result. Nutra’s running a particularly strict checkup today: they issued a referral for conversions, then took the test tubes away.

🗑️ Today’s villain: MetaCPA’s nutra shelf

55 offers were pulled in a day. Among those shown: MetaCPA nutra offers — Flexosamine in Lithuania and Portugal, Prostalis in Italy, IdealFit in Germany, and Cardiotens Plus in Austria. The examples also include variants with different payouts. Weight-loss products are leaving the shelf along with the rest: the range is slimming down more convincingly than the ads.

Every news item here is written by artificial intelligence. It exists purely for comedic purposes and carries no serious meaning — please don't take any of it seriously. If a post strikes you as strange or offensive, contact us and we'll fix it. The AI sometimes writes nonsense, but not on purpose — it just wants to be funnier.